Skip to main content

Advertisement

Log in

The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Background

It has recently been found that 5-lipoxygenase (5-LO) and cytochrome P450-2J2 (CYP2J2), molecules capable of arachidonic acid (AA) metabolism, might promote cancer cell viability through several mechanisms similar to those of cyclooxygenase-2 (COX-2). We found that not only COX-2 expression, but also the expression of 5-LO and CYP2J2 is up-regulated in head and neck squamous cell carcinoma (HNSCC) cell lines. From these observations, we hypothesized that AA metabolism by 5-LO and/or CYP2J2 may lower the efficacy of anti-cancer effect by COX-2 inhibition.

Methods and Results

Although COX-2 was highly expressed in all cell lines tested, COX-2-specific inhibition showed little growth-inhibitory effect in some cell lines. Inhibition of COX-2 resulted in increased production of LTB4 and 14-15-DHET/EET, metabolites of 5-LO and CYP2J2, respectively. Combined knock-down of COX-2 and 5-LO or CYP2J2 by siRNA results in a decrease in cell proliferation and VEGF production. Furthermore, these results are dependent on 5-LO and CYP2J2 expression in cells.

Conclusion

Therefore, combined inhibition of COX-2 and 5-LO or CYP2J2 may be one way to overcome low efficacy of single inhibition of COX-2 in cancer cells. In addition, combined therapies should be chosen based on the expression of members of other AA metabolism pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

siRNA:

small interfering RNA

CYP2J2:

cytochrome P450 family 2-subfamily J-polypeptide 2

PGE2 :

prostaglandin E2

LTB4 :

Leukotriene B4

DHET:

dihydroxyeicosatrienoic acid

EET:

epoxyeicosatrienoic acid

VEGF:

vascular endothelial growth factor

5-HETE:

5-Hydroxyeicosatetraenoic acid

cytLTs:

cysteinyl-leukotrienes

References

  1. H. Harizi, J.B. Corcuff, N. Gualde, Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol. Med. 14, 461–469 (2008)

    Article  PubMed  CAS  Google Scholar 

  2. S.P. Levick, D.C. Loch, S.M. Taylor, J.S. Janicki, Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J. Immunol. 178, 641–646 (2007)

    PubMed  CAS  Google Scholar 

  3. Y. Zheng, J.D. Ritzenthaler, X. Sun, J. Roman, S. Han, Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1. Cancer Res. 69, 896–904 (2009)

    Article  PubMed  CAS  Google Scholar 

  4. N. Arber, Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point. Cancer Epidemiol. Biomarkers Prev. 17, 1852–1857 (2008)

    Article  PubMed  CAS  Google Scholar 

  5. W.G. Tong, X.Z. Ding, M.S. Talamonti, R.H. Bell, T.E. Adrian, LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem. Biophys. Res. Commun. 335, 949–956 (2005)

    Article  PubMed  CAS  Google Scholar 

  6. J.G. Jiang, Y.G. Ning, C. Chen, D. Ma, Z.J. Liu, S. Yang, J. Zhou, X. Xiao, X.A. Zhang, M.L. Edin, J.W. Card, J. Wang, D.C. Zeldin, D.W. Wang, Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res. 67, 6665–6674 (2007)

    Article  PubMed  CAS  Google Scholar 

  7. Y.N. Ye, W.K. Wu, V.Y. Shin, I.C. Bruce, B.C. Wong, C.H. Cho, Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 26, 827–834 (2005)

    Article  PubMed  CAS  Google Scholar 

  8. F. Cianchi, C. Cortesini, L. Magnelli, E. Fanti, L. Papucci, N. Schiavone, L. Messerini, A. Vannacci, S. Capaccioli, F. Perna, M. Luli, V. Fabbroni, G. Perigli, P. Bechi, E. Masini, Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells. Mol. Cancer Ther. 5, 2716–2726 (2006)

    Article  PubMed  CAS  Google Scholar 

  9. M. Barry, R.A. Cahill, G. Roche-Nagle, T.G. Neilan, A. Treumann, J.H. Harmey, D.J. Bouchier-Hayes, Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer. Ir. J. Med. Sci. 178, 201–208 (2009)

    Article  PubMed  CAS  Google Scholar 

  10. S.W. Park, S.G. Lee, S.H. Song, D.S. Heo, B.J. Park, D.W. Lee, K.H. Kim, M.W. Sung, The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int. J. Cancer 107, 729–738 (2003)

    Article  PubMed  CAS  Google Scholar 

  11. C. Vincent, R. Fiancette, M. Donnard, D. Bordessoule, P. Turlure, F. Trimoreau, Y. Denizot, 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts. Leuk. Res. 32, 1756–1762 (2008)

    Article  PubMed  CAS  Google Scholar 

  12. T.C. Delozier, G.E. Kissling, S.J. Coulter, D. Dai, J.F. Foley, J.A. Bradbury, E. Murphy, C. Steenbergen, D.C. Zeldin, J.A. Goldstein, Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab. Dispos. 35, 682–688 (2007)

    Article  PubMed  CAS  Google Scholar 

  13. A. Catalano, A. Procopio, New aspects on the role of lipoxygenases in cancer progression. Histol. Histopathol. 20, 969–975 (2005)

    PubMed  CAS  Google Scholar 

  14. V.B. O’Donnell, B. Maskrey, G.W. Taylor, Eicosanoids: generation and detection in mammalian cells. Methods Mol. Biol. 462, 5–23 (2009)

    PubMed  Google Scholar 

  15. L.G. Melstrom, D.J. Bentrem, M.R. Salabat, T.J. Kennedy, X.Z. Ding, M. Strouch, S.M. Rao, R.C. Witt, C.A. Ternent, M.S. Talamonti, R.H. Bell, T.A. Adrian, Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin. Cancer Res. 14, 6525–6530 (2008)

    Article  PubMed  CAS  Google Scholar 

  16. H. Zhu, W. Glasgow, M.D. George, K. Chrysovergis, K. Olden, J.D. Roberts, T. Eling, 15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity. Int. J. Cancer 123, 2741–2749 (2008)

    Article  PubMed  CAS  Google Scholar 

  17. Q. Yang, Y. Feng, C.J. Schultz, X.A. Li, H. Wu, D. Wang, Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer. Cancer Gene Ther. 15, 323–330 (2008)

    Article  PubMed  CAS  Google Scholar 

  18. J.G. Jiang, X.N. Fu, C.L. Chen, D.W. Wang, Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines. Chin. J. Cancer 28, 93–96 (2009)

    CAS  Google Scholar 

  19. J.G. Jiang, C.L. Chen, J.W. Card, S. Yang, J.X. Chen, X.N. Fu, Y.G. Ning, X. Xiao, D.C. Zeldin, D.W. Wang, Cytochrome P450 2 J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res. 65, 4707–4715 (2005)

    Article  PubMed  CAS  Google Scholar 

  20. J.L. Roh, M.W. Sung, S.W. Park, D.S. Heo, D.W. Lee, K.H. Kim, Celecoxib can prevent tumor growth and distant metastasis in postoperative setting. Cancer Res. 64, 3230–3235 (2004)

    Article  PubMed  CAS  Google Scholar 

  21. M.W. Sung, J.L. Roh, B.J. Park, S.W. Park, T.K. Kwon, S.J. Lee, K.H. Kim, Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 113, 1059–1063 (2003)

    Article  PubMed  CAS  Google Scholar 

  22. S.W. Park, M.W. Sung, D.S. Heo, H. Inoue, S.H. Shim, K.H. Kim, Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines. Oncogene 24, 6689–6698 (2005)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. William L. Smith, Dr. Thomas G. Brock and Darryl C. Zeldin for kindly providing us with the cDNA of COX-2, 5-LO and CYP2J2.

This study was supported by a grant from the national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [Grants no. 0620250] and BK21 project for Medicine, Dentistry and Pharmacy, Korea.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Myung-Whun Sung.

Electronic Supplementary Materials

Below is the link to the electronic supplementary material.

Supplementary material 1

(DOC 142 kb)

Supplementary material 2

(DOC 76 kb)

Supplementary material 3

(DOC 108 kb)

Supplementary material 4

(DOC 153 kb)

Supplementary material 5

(DOC 148 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, SW., Heo, DS. & Sung, MW. The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells. Cell Oncol. 35, 1–8 (2012). https://doi.org/10.1007/s13402-011-0051-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-011-0051-7

Keywords

Navigation